Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8
Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8
摩根士丹利将Centessa Pharmicals上调至同等权重，将目标股价提高至8美元
Morgan Stanley analyst Matthew Harrison upgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Underweight to Equal-Weight and raises the price target from $4 to $8.
摩根士丹利分析师马修·哈里森将Centessa Pharmicals（纳斯达克股票代码：CNTA）从减持上调至同等权重，并将目标股价从4美元上调至8美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。